Dashboard
Manage Tickers

CRVSCorvus Pharmaceuticals, Inc.

Nasdaq corvuspharma.com


$ 1.51 $ -0.03 (-2.03 %)    

Friday, 26-Apr-2024 13:49:47 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.04 $ -2.11 (-0.49 %)
DIA $ 383.28 $ 0.09 (0.02 %)
SPY $ 509.12 $ -1.19 (-0.23 %)
TLT $ 88.63 $ -0.03 (-0.03 %)
GLD $ 215.44 $ -0.61 (-0.28 %)
$ 1.45
$ 1.53
$ 0.00 x 0
$ 0.00 x 0
$ 1.51 - $ 1.60
$ 1.00 - $ 4.19
124,494
na
69.64M
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-19-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 03-28-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 03-10-2022 12-31-2021 10-K
10 11-01-2021 09-30-2021 10-Q
11 08-02-2021 06-30-2021 10-Q
12 04-29-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 10-29-2020 09-30-2020 10-Q
15 07-30-2020 06-30-2020 10-Q
16 04-30-2020 03-31-2020 10-Q
17 03-09-2020 12-31-2019 10-K
18 10-30-2019 09-30-2019 10-Q
19 08-01-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-07-2019 12-31-2018 10-K
22 11-01-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-03-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-02-2017 09-30-2017 10-Q
27 08-03-2017 06-30-2017 10-Q
28 05-04-2017 03-31-2017 10-Q
29 03-10-2017 12-31-2016 10-K
30 11-03-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 20:31:18

corvus-pharmaceuticals-announces-initiation-of-placebo-controlled-phase-1-clinical-trial-of-soquelitinib-for-atopic-dermatitis
Corvus Pharmaceuticals Announces Initiatio...
04/09/2024 20:02:18

Atopic dermatitis is the first immune disease indication being studied in the clinic for soquelitinib, the Company's select...

cantor-fitzgerald-reiterates-overweight-on-corvus-pharma
Cantor Fitzgerald Reiterates Overweight on...
04/01/2024 15:16:33

Cantor Fitzgerald analyst Li Watsek reiterates Corvus Pharma (NASDAQ:CRVS) with a Overweight.

mizuho-maintains-neutral-on-corvus-pharma-maintains-35-price-target
Mizuho Maintains Neutral on Corvus Pharma,...
03/27/2024 17:21:58

Mizuho analyst Graig Suvannavejh maintains Corvus Pharma (NASDAQ:CRVS) with a Neutral and maintains $3.5 price target.

oppenheimer-maintains-outperform-on-corvus-pharma-lowers-price-target-to-7
Oppenheimer Maintains Outperform on Corvus...
03/20/2024 11:14:14

Oppenheimer analyst Jeff Jones maintains Corvus Pharma (NASDAQ:CRVS) with a Outperform and lowers the price target from $8 t...

corvus-pharma-q4-eps-014-misses-012-estimate
Corvus Pharma Q4 EPS $(0.14) Misses $(0.12...
03/19/2024 20:04:29

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.1...

earnings-scheduled-for-march-19-2024
Earnings Scheduled For March 19, 2024
03/19/2024 10:06:23

Companies Reporting Before The Bell • Tencent Music Enter Gr (NYSE:TME) is projected to report quarterly earnings at $0.14 per...

earnings-outlook-for-corvus-pharma
Earnings Outlook For Corvus Pharma
03/18/2024 14:00:39

corvus-pharmaceuticals-presents-soquelitinib-preclinical-data-at-keystone-symposia-on-systemic-autoimmune-and-autoinflammatory-diseases
Corvus Pharmaceuticals Presents Soquelitin...
02/12/2024 13:31:23

The poster presentation includes the first description of Corvus' next-generation ITK inhibitor preclinical product candida...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/09/2024 13:06:11

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
02/08/2024 21:31:10

corvus-pharmaceuticals-says-fda-granted-orphan-drug-designation-for-soquelitinib-for-treatment-of-t-cell-lymphoma
Corvus Pharmaceuticals Says FDA Granted Or...
02/08/2024 21:09:37

Soquelitinib, the Company's lead ITK inhibitor candidate, is expected to advance into a Phase 3 registrational clinical tri...

why-green-giant-shares-are-trading-lower-by-around-37-here-are-20-stocks-moving-premarket
Why Green Giant Shares Are Trading Lower B...
12/11/2023 12:59:28

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Gre...

saturday-corvus-pharmaceuticals-announced-new-interim-data-from-phase-11b-trial-of-soquelitinib-for-relapsed-peripheral-t-cell-lymphoma-demonstrating-durable-anti-tumor-activity-and-overall-survival-rates-exceeding-current-standard-of-care-therapies
Saturday, Corvus Pharmaceuticals Announced...
12/11/2023 10:07:22

corvus-pharma-q3-eps-012-inline
Corvus Pharma Q3 EPS $(0.12), Inline
11/07/2023 22:06:17

Corvus Pharma (NASDAQ:CRVS) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a ...

earnings-scheduled-for-november-7-2023
Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

preview-corvus-pharmas-earnings
Preview: Corvus Pharma's Earnings
11/06/2023 16:00:58

corvus-pharmaceuticals-to-present-new-interim-soquelitinib-data-from-its-phase-11b-t-cell-lymphoma-trial-at-the-65th-ash-annual-meeting--exposition
Corvus Pharmaceuticals To Present New Inte...
11/02/2023 13:21:33

reported-earlier-corvus-pharmaceuticals-publishes-preclinical-data-demonstrating-potential-of-itk-inhibition-with-soquelitinib-as-a-novel-approach-to-t-cell-mediated-inflammatory-and-immune-diseases
Reported Earlier, Corvus Pharmaceuticals P...
11/02/2023 06:32:56

why-toro-are-trading-lower-by-14-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Toro Are Trading Lower By 14%? Here Ar...
09/07/2023 17:19:11

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champi...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION